Biogen Strikes Forward With Skill Alzheimer’s Drug, Seeks US Approval
(Reuters) – Biogen Inc said on Wednesday it submitted an application seeking U.S. approval of its closely watched Alzheimer’s drug, as the firm targets to be the principle to lift a treatment to market that can alter the direction of…